CytoMed Therapeutics Ltd banner

Wall St Price Targets

GDTC Price Forecast
No price targets yet

We don't have analyst price targets for GDTC yet.

GDTC Analyst Rating
Based on 1 analyst

avg. 5 of 5
Strong buy
1 100%
Buy
0 0%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

The analyst rating for GDTC is Strong buy.

CytoMed Therapeutics Ltd Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GDTC's stock price target?
Not Available

GDTC does not have any price targets made by Wall Street professionals.

What is the Gross Profit forecast for CytoMed Therapeutics Ltd?
Projected CAGR
-8%

The compound annual growth rate for Gross Profit over the next -2 years is -8%.

Back to Top